scorecardresearch
Add as a preferred source on Google
Sunday, November 30, 2025
TopicCovid vaccines

Topic: Covid vaccines

Centre has allocated only 15 lakh Covid vaccine doses to Delhi for July: Manish Sisodia

The Deputy CM Monday called India's vaccination drive 'mismanaged' and added that it will take around 16 more months to inoculate Delhi's entire population at the current rate.

Covid vaccine awareness drive to begin tomorrow with help from Muslim clerics to fight ‘rumours’

'Jaan Hai To Jahaan Hai' will be launched from UP's Rampur district. The aim is to tackle vaccine hesitancy across the country, with aid from religious leaders, NGOs and minority organisations.

To launch J&J Covid shot in India, Biological E begins talks with govt lab to test vaccine

Hyderabad-based Biological E has been contracted by American J&J to mass manufacture its one-shot vaccine.

Vaccination picks up pace with 35 lakh shots given in last 24 hrs, but still a long way to go

If India administers an average of 31 lakh doses a day, it will take more than a year to vaccinate the entire population.

Covovax vaccine samples cleared by national drug lab, phase 3 trials could begin by July

Covovax, Novavax's Indian version, will be tested on 1,400 volunteers across 20 cities by Serum Institute, which has already begun production of the Covid vaccine.

Pune cell science centre could soon get Modi govt nod to test and approve Covid vaccines

If given a go-ahead, National Centre for Cell Science will be the 2nd centre after Central Drugs Laboratory, Kasauli, to test Covid-19 vaccines.

Covid immunity lasts for a year, vaccine boost helps fight variants, study says

The study in journal Nature says ability of vaccine-induced antibodies to neutralise variants of concern was comparable to or greater than that against the original strain.

Complex manufacturing, R&D, risks, losses — Bharat Biotech explains why Covaxin is expensive

Bharat Biotech also says Rs 150 per dose price for the government is 'non-competitive' and not sustainable in the long run.

Pfizer, AstraZeneca vaccines provide ‘good protection’ against Delta variant: Lancet study

The study finds Pfizer's Covid vaccine offers 79 per cent protection and the AstraZeneca vaccine, known as Covishield in India, secures 60 per cent protection against Covid strain.

At-home vaccination to taxi ambulance — how this IAS officer in Chennai tackled 2nd Covid wave

A selection of the best news reports, analysis and opinions published by ThePrint this week.

On Camera

There’s pollution, violence, volcanic ash on my screen. And yet an email is more stressful

Years are quietly being stripped off my lifespan, and somehow that doesn’t ruin my day. But getting scolded for one careless word in an email? That can send me spiralling.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.